This is because CERT inhibition leads to an increase in intracellular ceramide levels by blocking the conversion of ceramide to SM, which could be a potential strategy for cancer treatment, as well a way to increase the efficacy of existing anticancer drugs. The gene discussed is CERT1; the disease is cancer.